arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2007-13-2-149-155arthyper-1121Research ArticleКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯCLINICAL TRIALSТерапевтическая инертность как причина
неконтролируемой артериальной гипертонии
в амбулаторной практике: результаты
исследования АРГУС-2Uncontrolled hypertension in out-patient
clinic - therapueutic regidity as a cause: results
of ARGUS-2КобалаваЖ. Д.KobalavaG. D.noemail@neicon.ruКотовскаяЮ. В.KotovskayaYu. V.noemail@neicon.ruСтаростинаЕ. Г.StarostinaE. G.noemail@neicon.ruДроздецкийС. И.DrozdetskiS. I.noemail@neicon.ruБогачевР. С.BogachevR. S.noemail@neicon.ru200728042007132149155Copyright © Кобалава Ж.Д., Котовская Ю.В., Старостина Е.Г., Дроздецкий С.И., Богачев Р.С., 20072007Кобалава Ж.Д., Котовская Ю.В., Старостина Е.Г., Дроздецкий С.И., Богачев Р.С.Kobalava G.D., Kotovskaya Y.V., Starostina E.G., Drozdetski S.I., Bogachev R.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/1121ReferencesПрофилактика, диагностика и лечение артериальной гипертензии. Российские рекомендации (второй пересмотр). Кардиваскулярная терапия и профилактика, приложение. 2004;с.20.Профилактика, диагностика и лечение артериальной гипертензии. Российские рекомендации (второй пересмотр). Кардиваскулярная терапия и профилактика, приложение. 2004;с.20.Chobanian A.V., Bakris G.L., Black H.R. et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.Chobanian A.V., Bakris G.L., Black H.R. et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992.World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992.European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.Okonofua EC et al. Hypertension. 2006; 47:345-351.Okonofua EC et al. Hypertension. 2006; 47:345-351.Fine L.J., Cutler J.A. Hypertension. 2006; 47:319-320.Fine L.J., Cutler J.A. Hypertension. 2006; 47:319-320.Hansson L., Zanchetti A., Carruthers S.G. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet.l998;351:1755-1762.Hansson L., Zanchetti A., Carruthers S.G. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet.l998;351:1755-1762.Psaty B.M., Lumley Т., Furberg C.D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-2544Psaty B.M., Lumley Т., Furberg C.D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-2544Kostis J.B., Wilson A.C. Fredenberger R.S. et al. Long- term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95:29-35.Kostis J.B., Wilson A.C. Fredenberger R.S. et al. Long- term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95:29-35.Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165:1410-1419.Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165:1410-1419.Moser M. Diuretics should continue to be one of the preferred initial therapies in the management of hypertension. The argument for. J Clin Hypertens. 2005;7:111-116Moser M. Diuretics should continue to be one of the preferred initial therapies in the management of hypertension. The argument for. J Clin Hypertens. 2005;7:111-116PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl). 1995;108:710-717.PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl). 1995;108:710-717.Gosse P., Sheridan P., Zannad F.al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens. 2000;18:1465-1475.Gosse P., Sheridan P., Zannad F.al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens. 2000;18:1465-1475.Marre M., Puig J.G., Kokot F. et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. J Hypertens. 2004;22:1613-1622.Marre M., Puig J.G., Kokot F. et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. J Hypertens. 2004;22:1613-1622.London G., Schmiede R., Calvo C. Antihypertensive efficacy of indapamide SR vs candesartan and amlodipine in hypertensive patients: the X-cellent main study J Hypertens 2004;22 (suppl.2):S384 S1 13.London G., Schmiede R., Calvo C. Antihypertensive efficacy of indapamide SR vs candesartan and amlodipine in hypertensive patients: the X-cellent main study J Hypertens 2004;22 (suppl.2):S384 S1 13.London G., Schmiede R., Calvo C. Indapamide SR antihypertensive efficacy vs candesartan and amlodipine in isolated systolic hypertensive patients: the X-cellent ISH substudy. J Hypertens 2004;22 (suppl.2):S384 S1 13.London G., Schmiede R., Calvo C. Indapamide SR antihypertensive efficacy vs candesartan and amlodipine in isolated systolic hypertensive patients: the X-cellent ISH substudy. J Hypertens 2004;22 (suppl.2):S384 S1 13.
The authors declare that there are no conflicts of interest present.